SCHEMBL20122460

SCHEMBL20122460

CC(C)(S)C(=O)N[C@@H](CSC(=O)c1cccs1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 3/20 0.51
▸ MME P08473 1/20 0.51
▸ ACE2 Q9BYF1 1/20 0.51
▸ MAPT P10636 1/20 0.50
▸ ADAM17 P78536 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ TSHR P16473 2/20 0.39
▸ ERCC5 P28715 1/20 0.39
▸ FEN1 P39748 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ RAB9A P51151 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ CTSL P07711 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122473 0.87 MAPT (0.46) ACEMMEACE2MAPTADAM17
SCHEMBL9630045 0.84 MAPT (0.52) MAPTADAM17KMT2AATMERCC5
SCHEMBL9630054 0.84 MAPT (0.52) MAPTADAM17KMT2AATMERCC5
SCHEMBL11385542 0.82 KMT2A (0.53) MAPTADAM17KMT2AATMTSHR
SCHEMBL11385539 0.82 KMT2A (0.53) MAPTADAM17KMT2AATMTSHR
SCHEMBL11384637 0.79 KMT2A (0.50) ACEMAPTADAM17KMT2AATM
SCHEMBL11384632 0.79 KMT2A (0.50) ACEMAPTADAM17KMT2AATM
SCHEMBL20122454 0.77 MAPT (0.45) ACEMMEACE2MAPTADAM17
SCHEMBL20122459 0.76 ACE (0.51) ACEMMEACE2MAPTKMT2A
SCHEMBL20122512 0.74 MAPT (0.34) MAPTADAM17KMT2AATMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback